These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 15834715)

  • 41. Advances in the production and downstream processing of antibodies.
    Chon JH; Zarbis-Papastoitsis G
    N Biotechnol; 2011 Sep; 28(5):458-63. PubMed ID: 21515428
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Towards the implementation of quality by design to the production of therapeutic monoclonal antibodies with desired glycosylation patterns.
    del Val IJ; Kontoravdi C; Nagy JM
    Biotechnol Prog; 2010; 26(6):1505-27. PubMed ID: 20665659
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A systematic approach for scale-down model development and characterization of commercial cell culture processes.
    Li F; Hashimura Y; Pendleton R; Harms J; Collins E; Lee B
    Biotechnol Prog; 2006; 22(3):696-703. PubMed ID: 16739951
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High cell density fed batch and perfusion processes for stable non-viral expression of secreted alkaline phosphatase (SEAP) using insect cells: comparison to a batch Sf-9-BEV system.
    Jardin BA; Montes J; Lanthier S; Tran R; Elias C
    Biotechnol Bioeng; 2007 Jun; 97(2):332-45. PubMed ID: 17054119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bcl-x(L) mediates increased production of humanized monoclonal antibodies in Chinese hamster ovary cells.
    Chiang GG; Sisk WP
    Biotechnol Bioeng; 2005 Sep; 91(7):779-92. PubMed ID: 15986489
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-apoptotic genes Aven and E1B-19K enhance performance of BHK cells engineered to express recombinant factor VIII in batch and low perfusion cell culture.
    Nivitchanyong T; Martinez A; Ishaque A; Murphy JE; Konstantinov K; Betenbaugh MJ; Thrift J
    Biotechnol Bioeng; 2007 Nov; 98(4):825-41. PubMed ID: 17514750
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Perfusion culture of hybridoma cells for hyperproduction of IgG(2a) monoclonal antibody in a wave bioreactor-perfusion culture system.
    Tang YJ; Ohashi R; Hamel JF
    Biotechnol Prog; 2007; 23(1):255-64. PubMed ID: 17269696
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Technological progresses in monoclonal antibody production systems.
    Rodrigues ME; Costa AR; Henriques M; Azeredo J; Oliveira R
    Biotechnol Prog; 2010; 26(2):332-51. PubMed ID: 20043321
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Membrane-based cell culture systems--an alternative to in vivo production of monoclonal antibodies.
    Nagel A; Koch S; Valley U; Emmrich F; Marx U
    Dev Biol Stand; 1999; 101():57-64. PubMed ID: 10566776
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bioprocessing of plant cell cultures for mass production of targeted compounds.
    Georgiev MI; Weber J; Maciuk A
    Appl Microbiol Biotechnol; 2009 Jul; 83(5):809-23. PubMed ID: 19488748
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nonperfused attachment systems for cell cultivation.
    Elliott AY
    Bioprocess Technol; 1990; 10():207-16. PubMed ID: 1367060
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fed-batch and perfusion culture processes: economic, environmental, and operational feasibility under uncertainty.
    Pollock J; Ho SV; Farid SS
    Biotechnol Bioeng; 2013 Jan; 110(1):206-19. PubMed ID: 22806692
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suspension culture of mammalian cells.
    Birch JR; Arathoon R
    Bioprocess Technol; 1990; 10():251-70. PubMed ID: 1367062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Defined protein and animal component-free NS0 fed-batch culture.
    Spens E; Häggström L
    Biotechnol Bioeng; 2007 Dec; 98(6):1183-94. PubMed ID: 17516495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent advances in technology supporting biopharmaceutical production from mammalian cells.
    Butler M; Meneses-Acosta A
    Appl Microbiol Biotechnol; 2012 Nov; 96(4):885-94. PubMed ID: 23053101
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification and prevention of antibody disulfide bond reduction during cell culture manufacturing.
    Trexler-Schmidt M; Sargis S; Chiu J; Sze-Khoo S; Mun M; Kao YH; Laird MW
    Biotechnol Bioeng; 2010 Jun; 106(3):452-61. PubMed ID: 20178122
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cell banking.
    Wiebe ME; May LH
    Bioprocess Technol; 1990; 10():147-60. PubMed ID: 1367056
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An animal origin perspective of common constituents of serum-free medium formulations.
    Jayme DW
    Dev Biol Stand; 1999; 99():181-7. PubMed ID: 10404889
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transcriptome and proteome analysis of antibody-producing mouse myeloma NS0 cells cultivated at different cell densities in perfusion culture.
    Krampe B; Swiderek H; Al-Rubeai M
    Biotechnol Appl Biochem; 2008 Jul; 50(Pt 3):133-41. PubMed ID: 18302537
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bioreactor and process design for large-scale mammalian cell culture manufacturing.
    Nelson KL; Geyer S
    Bioprocess Technol; 1991; 13():112-43. PubMed ID: 1367130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.